David Bailey
Stock Analyst at Morgan Stanley
(3.56)
# 2,155
Out of 4,421 analysts
195
Total ratings
43.8%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Downgraded: Hold | n/a | $26.50 | - | 27 | Jun 18, 2026 | |
| RMD ResMed | Downgraded: Hold | $310 → $230 | $186.29 | +23.46% | 15 | Jun 17, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $2.90 → $3.50 | $2.03 | +72.41% | 2 | Jun 3, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Sell | $32.90 | $39.30 | -16.28% | 35 | Jun 1, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $40.00 | $38.78 | +3.15% | 10 | May 25, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $166.00 → $236.01 | $108.08 | +118.37% | 29 | May 24, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $22.40 | $14.32 | +56.42% | 14 | May 24, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $34.40 → $29.30 | $29.76 | -1.55% | 14 | May 6, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Downgraded: Sell | $25.20 → $20.30 | $19.84 | +2.32% | 18 | May 6, 2026 | |
| ASX: COH Cochlear Limited | Upgraded: Hold | $194.00 → $119.00 | $114.29 | +4.12% | 14 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $127.50 → $152.50 | $167.61 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.50 → $1.35 | $0.39 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.55 | $6.16 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.93 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.36 | $2.36 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $1.02 | n/a | 1 | Jan 21, 2021 |
ResMed Inc.
Jun 18, 2026
Downgraded: Hold
Price Target: n/a
Current: $26.50
Upside: -
ResMed
Jun 17, 2026
Downgraded: Hold
Price Target: $310 → $230
Current: $186.29
Upside: +23.46%
Integral Diagnostics Limited
Jun 3, 2026
Maintained: Buy
Price Target: $2.90 → $3.50
Current: $2.03
Upside: +72.41%
Ramsay Health Care Limited
Jun 1, 2026
Maintained: Sell
Price Target: $32.90
Current: $39.30
Upside: -16.28%
Fisher & Paykel Healthcare Corporation Limited
May 25, 2026
Maintained: Buy
Price Target: $40.00
Current: $38.78
Upside: +3.15%
CSL Limited
May 24, 2026
Reiterated: Buy
Price Target: $166.00 → $236.01
Current: $108.08
Upside: +118.37%
Telix Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $22.40
Current: $14.32
Upside: +56.42%
Ansell Limited
May 6, 2026
Maintained: Hold
Price Target: $34.40 → $29.30
Current: $29.76
Upside: -1.55%
Sonic Healthcare Limited
May 6, 2026
Downgraded: Sell
Price Target: $25.20 → $20.30
Current: $19.84
Upside: +2.32%
Cochlear Limited
Apr 23, 2026
Upgraded: Hold
Price Target: $194.00 → $119.00
Current: $114.29
Upside: +4.12%
Aug 15, 2024
Maintained: Buy
Price Target: $127.50 → $152.50
Current: $167.61
Upside: n/a
Feb 28, 2024
Maintained: Hold
Price Target: $1.50 → $1.35
Current: $0.39
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $3.05 → $3.55
Current: $6.16
Upside: n/a
Aug 24, 2021
Maintained: Hold
Price Target: n/a
Current: $13.93
Upside: n/a
Jan 21, 2021
Maintained: Hold
Price Target: $0.36
Current: $2.36
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $1.02
Upside: n/a